Galot, R., Le Tourneau, C., Saada-Bouzid, E., Daste, A., Even, C., Debruyne, P., Henry, S., Zanetta, S., Rutten, A., Licitra, L., Canon, J., Kaminsky, M., Specenier, P., Rottey, S., Guigay, J., Kong, A., Tinhofer, I., Borcoman, E., Dirix, L., Raveloarivahy, T., Fortpied, C., Vanlancker, M., Morfouace, M., Govaerts, A., & Machiels, J. (2021). a phase II study of monalizumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: The I1 cohort of the EORTC-HNCG-1559 UPSTREAM trial. European journal of cancer, 158, 17–26. http://access.bl.uk/ark:/81055/vdc_100145644977.0x000033